Stelara
Generic name: Ustekinumab
Dosage form: subcutaneous injection single-dose prefilled syringe (45 mg/0.5 mL or 90 mg/mL), subcutaneous injection single-dose vial (45 mg/0.5 mL), intravenous Infusion single-dose vial 130 mg/26 mL (5 mg/mL)
Drug class:
Interleukin inhibitors
Usage of Stelara
Stelara (ustekinumab) is used to treat types of plaque psoriasis, psoriatic arthritis, Crohn’s disease, and ulcerative colitis, which are all autoimmune conditions. Stelara injection is an interleukin inhibitor that works by blocking certain proteins in your body called IL-12 (interleukin-12) and IL-23 (interleukin-23) that cause inflammation in these autoimmune conditions. Stelara works by blocking the activity of IL-12 and IL-23, which reduces inflammation, pain, swelling, and skin symptoms that you may have.
Stelara is usually given as an injection under the skin (suBCutaneous injection), and for Crohn’s disease and ulcerative colitis, the first dose is given as an IV infusion.
Stelara was first FDA-approved on September 25, 2009, for adults with moderate to severe psoriasis, and since then, approval has been extended to include other conditions. Stelara is a biologic medicine and was the first brand of ustekinumab to be FDA-approved, so it is called the reference product. An interchangeable biosimilar of ustekinumab was approved on October 31, 2023, called Wezlana.
Stelara side effects
Common Stelara side effects may include:
Serious Stelara side effects:
Get emergency medical help if you have signs of an allergic reaction to Stelara: hives; chest pain, difficult breathing; feeling light-headed; swelling of your face, lips, tongue, or throat.
Serious infections may occur during treatment with Stelara. Call your doctor right away if you have signs of infection such as: fever, chills, muscle pain, shortness of breath, weight loss, diarrhea or stomach pain, burning when you urinate, feeling very tired, skin warmth or redness, painful skin sores, or coughing up blood.
Also call your doctor at once if you have:
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Before taking Stelara
You should not use Stelara injection or infusion if you:
Tell your doctor if you have ever had tuberculosis, if anyone in your household has tuberculosis, or if you have recently traveled to an area where tuberculosis is common.
To make sure Stelara is safe for you, tell your doctor if you have:
Some people using this medicine have developed skin cancer (non-melanoma). However, these people may have had a higher risk of skin cancer. Talk to your doctor about this risk and what skin symptoms to watch for. You may need to have regular skin exams.
Pregnancy
It is not known whether this medicine will harm an unborn baby. Tell your doctor if you are pregnant or plan to become pregnant. If you are pregnant, your name may be listed on a pregnancy registry to track the effects of ustekinumab on the baby.
Breastfeeding
It may not be safe to breast-feed while using this medicine. It is thought that Stelara passes into your breast milk in small amounts. Talk to your doctor about the best way to feed your baby if you receive this medicine.
Relate drugs
- Actemra
- Actemra ACTPen
- Adbry
- Arcalyst
- Cosentyx
- Basiliximab
- Benralizumab
- Brodalumab
- Canakinumab
- Cinqair
- Daclizumab
- Dupilumab
- Dupixent
- Dupixent Pre-filled Pen
- Dupixent Pre-filled Syringe
- Enspryng
- Fasenra
- Fasenra Pen
- Fasenra Prefilled Syringe
- Guselkumab
- Ilaris
- Ilumya
- Ixekizumab
- Mepolizumab
- Nucala
- Reslizumab
- Rilonacept
- Risankizumab
- Risankizumab-rzaa
- Satralizumab
- Satralizumab-mwge
- secukinumab
- Siliq
- Siltuximab
- Simulect
- Skyrizi
- Skyrizi Pen
- Spesolimab
- Spesolimab-sbzo
- Spevigo
- Stelara
- Sylvant
- Taltz
- Tildrakizumab
- Tildrakizumab-asmn
- Tocilizumab
- Tralokinumab
- Tralokinumab-ldrm
- Tremfya
- Ustekinumab
- Zinbryta
How to use Stelara
Crohn’s disease and ulcerative colitis Stelara is given as an infusion for the first dose then as a subcutaneous injection every 8 weeks thereafter.
Psoriasis and Psoriatic Arthritis Stelara is given as a subcutaneous injection initially and 4 weeks later, then a dose is given every 12 weeks.
Dose is dependent on the patient's weight.
For more Stelara dosing information, click on the link below.
Warnings
You should not use this medicine if you have received a BCG (Bacillus Calmette and Guérin) vaccine within 1 year prior to, during, or 1 year following treatment.
Before you start treatment with this injection, your doctor may perform tests to make sure you do not have tuberculosis.
Serious infections may occur during treatment with Stelara. Call your doctor right away if you have signs of infection such as fever, chills, muscle pain, shortness of breath, weight loss, diarrhea or stomach pain, burning when you urinate, feeling very tired, skin warmth or redness, painful skin sores, or coughing up blood.
Ustekinumab may also cause a rare but serious condition affecting the brain called Posterior Reversible Encephalopathy Syndrome (PRES). Tell your doctor right away if you have a headache, confusion, vision problems, or a seizure.
Stelara injection may decrease the activity of your immune system, and there may be an increase in your risk for certain types of cancers. Tell your doctor if you have ever had any type of cancer. Some people who are receiving this medicine and have risk factors for skin cancer have developed certain types of skin cancers. During your treatment with this medicine, tell your doctor if you develop any new skin growths.
What other drugs will affect Stelara
Other drugs may interact with Stelara, including prescription and over-the-counter medicines, vitamins, and herbal products. Tell your doctor about all your current medicines and any medicine you start or stop using.
It is important to tell your doctor if you are taking any of the following:
Your doctor may need to change the doses of your medications or monitor you carefully for side effects. Not all possible interactions are listed here.
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions